Science Pool

Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators

Posted by Evotec on Mar 4, 2021 9:47:46 PM

Tags: Neuroscience, Medicinal Chemistry, Articles & Whitepapers

Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors

Posted by Evotec on Mar 4, 2021 9:46:18 PM

Tags: Medicinal Chemistry, Respiratory, Articles & Whitepapers, Immunology & Inflammation

Restoration of Electrophysiological Alterations in Mouse Models of Huntington's Disease

Posted by Evotec on Mar 4, 2021 9:43:40 PM

Tags: Neuroscience, Articles & Whitepapers, In vivo Pharmacology

Drug Discovery Insights: Antisense Oligonucleotide Drug Discovery

Posted by Evotec on Mar 4, 2021 9:24:13 PM

Tags: Articles & Whitepapers, Biologics

Drug Discovery Insights: Expansion into Gene Therapy

Posted by Evotec on Mar 4, 2021 9:23:24 PM

Tags: Articles & Whitepapers, Biologics

Drug Discovery Insights: Evotec's Approach to Fighting Chikungunya

Posted by Evotec on Mar 4, 2021 9:20:41 PM

Tags: Articles & Whitepapers, Anti-Infectives

Drug Discovery Insights: Neurodegenerative Diseases Collaboration with Celgene

Posted by Evotec on Mar 4, 2021 9:20:01 PM

Tags: Neuroscience, Articles & Whitepapers

Drug Discovery Insight: Building Bridges to Accelerate Drug Discovery

Posted by Evotec on Mar 4, 2021 9:18:58 PM

Tags: Articles & Whitepapers

Drug Discovery Insight: Evotec and Bayer Partner to Fight Kidney Diseases

Posted by Evotec on Mar 4, 2021 9:18:00 PM

Tags: Kidney diseases, Articles & Whitepapers, Metabolic Disease & Complications

Drug Discovery Insight: Evotec's Alliance with Bayer to Fight Chronic Cough

Posted by Evotec on Mar 4, 2021 9:17:03 PM

Tags: Respiratory, Articles & Whitepapers